Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 269.30K | 977.40K | 1.28M | 1.30M | 2.62M |
| Total Receivables | 2.17M | 1.99M | 2.28M | 2.32M | 1.86M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 100.00 | 11.10K | 32.80K | 44.50K | 27.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.44M | 2.98M | 3.59M | 3.66M | 4.51M |
|
|
|||||
| Total Current Assets | 2.44M | 2.98M | 3.59M | 3.66M | 4.51M |
| Net Property, Plant & Equipment | 747.00K | 784.60K | 815.20K | 852.90K | 902.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 219.00K | 226.70K | 234.40K | 242.10K | 249.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.10K | 5.10K | 5.10K | 5.10K | 5.10K |
| Total Assets | 3.41M | 4.00M | 4.64M | 4.76M | 5.67M |
|
|
|||||
| Total Accounts Payable | 517.10K | 487.60K | 451.60K | 465.40K | 441.50K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.61M | 1.61M | 1.49M | 1.09M | 1.68M |
| Total Other Current Liabilities | 1.61M | 1.61M | 1.49M | 1.09M | 1.68M |
| Total Current Liabilities | 2.13M | 2.10M | 1.94M | 1.56M | 2.12M |
|
|
|||||
| Total Current Liabilities | 2.13M | 2.10M | 1.94M | 1.56M | 2.12M |
| Long-Term Debt | 363.90K | 363.90K | 363.90K | 363.90K | 353.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.36M | 5.35M | 5.35M | 5.34M | 5.33M |
| Total Liabilities | 7.85M | 7.82M | 7.65M | 7.26M | 7.81M |
|
|
|||||
| Common Stock & APIC | 50.12M | 50.12M | 50.12M | 50.07M | 50.07M |
| Retained Earnings | -54.86M | -54.23M | -53.42M | -52.87M | -52.49M |
| Treasury Stock & Other | 52.50K | 50.00K | 51.90K | 58.30K | 39.60K |
| Total Common Equity | -4.69M | -4.06M | -3.25M | -2.74M | -2.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 245.80K | 244.10K | 242.30K | 240.50K | 238.70K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 245.80K | 244.10K | 242.30K | 240.50K | 238.70K |
|
|
|||||
| Total Common Equity | -4.69M | -4.06M | -3.25M | -2.74M | -2.37M |
| Total Preferred Equity | 245.80K | 244.10K | 242.30K | 240.50K | 238.70K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.44M | -3.82M | -3.01M | -2.50M | -2.14M |
|
|
|||||